Skip to main content
Premium Trial:

Request an Annual Quote

'Bittersweet' Science


Immunologist Ralph Steinman was one of three researchers awarded this year's Nobel Prize in physiology or medicine for his discovery of dendritic cells. The prize is "bittersweet,"
ScienceInsider's Jennifer Couzin-Frankel says, as Steinman became the first winner to pass away days before the announcement of his win, but after the prize committee made its selection. Though the Nobel Foundation's policy precludes posthumous awards, the committee ultimately decided to honor Steinman for his work. Steinman's research on dendritic cells, a class of immune cells, eventually led to the development of the prostate cancer vaccine Provenge, which works by injecting a patient's own dendritic cells back into their body, Couzin-Frankel says. "Cancer vaccines either using or targeting dendritic cells are now the subject of numerous clinical trials," she adds. "Like all cancer vaccines, it's been a challenge to get dendritic cell immunotherapy to destroy tumors in people. The goal is to selectively activate certain T cells that are best-suited to target cancer." Because dendritic cells differ from person to person, the vaccines need to be personalized and that makes them expensive. Provenge, which costs $93,000 for three doses, extends life by about three months, Couzin-Frankel says. But researchers say that despite the difficulties involved, it is a validation of Steinman's work, and dendritic cell therapy is now being applied to various cancers, including — in a recent Journal of Clinical Oncology paper published by Steinman — brain cancer. Steinman even used the therapy on himself after he was diagnosed with pancreatic cancer, Couzin-Frankel adds.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.